| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |